europabio-logoeuropabio-logoeuropabio-logoeuropabio-logo
  • About us
    • Who we are
      • Governance
      • Staff
      • Vacancies
    • What we do
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Cell & Gene Therapies
      • Medicines For Rare Diseases And Children
      • Regulatory Efficiency
      • Biosimilars & Public Procurement
      • Data & Digital
      • Patient Bio-Forum
    • Industrial Biotechnology Council
      • Food, Feed & Nutrition
      • Circular Bioeconomy
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
  • Activities
    • 25 Years of Innovation
    • EFIB 2022
    • European Biotech Week
  • Events
  • Newsroom
    • News & Publications
    • Newsletter
    • Library
Become a member
✕

UNION Therapeutics joins EuropaBio: building a pipeline for inflammation and infectious diseases

14/04/2021
PRESS RELEASE

UNION Therapeutics joins EuropaBio: Building a pipeline for inflammation and infectious diseases

Brussels, 14 April 2021 – EuropaBio is pleased to announce that UNION Therapeutics has joined as a corporate member. Founded in 2011, UNION Therapeutics is a Danish bio-pharmaceutical company dedicated to the discovery and development of novel medicines in the fields of both inflammatory and infectious diseases.

In joining EuropaBio, UNION will work together with members to push for a European industrial strategy that enables SMEs to validate and scale up high potential candidates more quickly, building on the ecosystem advances seen during the response to Covid-19.

EuropaBio Director-General Dr. Claire Skentelbery says “UNION Therapeutics illustrates the high potential within the European ecosystem for high impact products in a world with a string demand for rapidly accessible innovation. We will be working with UNION to showcase how Europe can unlock the talents from its SMEs.

Dr. Kim Domela Kjøller, Chief Executive Officer at UNION Therapeutics, added “We’re delighted to join EuropaBio to strengthen the collective voice of SME’s in the European biotech industry. We have initiated our collaboration with EuropaBio in our ambition to cover the unmet demand of Covid-19 treatments for vulnerable patient groups and are looking forward to working together in several capacities going forward.".

Download the full PRESS RELEASE below.

UNION Therapeutics Website

UNION Therapeutics joins EuropaBio


Download
2021_04_G_PR_UNION-Therapeutics-joins-EuropaBioDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

23/03/2023

Unlocking the Potential of Biotechnology Innovation for Patients


Read more
16/03/2023

Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future


Read more
07/03/2023

Disc Medicine joins EuropaBio: life-changing medicines for patients with hematologic disorders


Read more
06/03/2023

Can the Pharmaceutical Strategy Deliver for Europe?


Read more

Important links

  • Unlocking the Potential of Biotechnology Innovation for Patients
  • Vision, clarity and enabling – the drivers for Europe’s biomanufacturing future

Categories in our Newsroom

Subscribe for our newsletter

Subscribe to the EuropaBio newsletter to receive the latest news and developments in the Biotech sector!


Subscribe
EuropaBio-Logo-White

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 2600 biotech companies, 2300 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2023 Europabio. All Rights Reserved. Designed by EYAS
Become a member
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkLegal & Cookies